Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 25
1976 45
1977 57
1978 82
1979 127
1980 130
1981 172
1982 212
1983 220
1984 260
1985 230
1986 198
1987 208
1988 215
1989 211
1990 216
1991 178
1992 142
1993 158
1994 161
1995 147
1996 120
1997 140
1998 140
1999 157
2000 193
2001 162
2002 155
2003 215
2004 181
2005 213
2006 240
2007 243
2008 225
2009 242
2010 222
2011 224
2012 262
2013 261
2014 321
2015 281
2016 271
2017 238
2018 249
2019 264
2020 286
2021 258
2022 253
2023 232
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

9,058 results

Results by year

Filters applied: . Clear all
Page 1
IL-6 translation is a therapeutic target of human cytokine release syndrome.
Yang Y, Zhang Y, Xing X, Xu G, Lin X, Wang Y, Chen M, Wang C, Zhang B, Han W, Hu X. Yang Y, et al. J Exp Med. 2023 Nov 6;220(11):e20230577. doi: 10.1084/jem.20230577. Epub 2023 Aug 16. J Exp Med. 2023. PMID: 37584653 Free PMC article.
Furthermore, an investigator-initiated phase I/II clinical trial demonstrated a favorable safety profile of metoprolol in CRS management and showed that metoprolol significantly alleviated CAR T-induced CRS without compromising CAR T efficacy. These results repurpos …
Furthermore, an investigator-initiated phase I/II clinical trial demonstrated a favorable safety profile of metoprolol in CRS managem …
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
POISE Study Group; Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. POISE Study Group, et al. Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12. Lancet. 2008. PMID: 18479744 Free article. Clinical Trial.
More patients in the metoprolol group than in the placebo group had a stroke (41 [1.0%] vs 19 [0.5%] patients; 2.17, 1.26-3.74; p=0.0053). ...Patients are unlikely to accept the risks associated with perioperative extended-release metoprolol....
More patients in the metoprolol group than in the placebo group had a stroke (41 [1.0%] vs 19 [0.5%] patients; 2.17, 1.26-3.74; p=0.0 …
Metoprolol succinate combination in the treatment of hypertension.
Papadopoulos DP, Papademetriou V. Papadopoulos DP, et al. Angiology. 2009 Oct-Nov;60(5):608-13. doi: 10.1177/0003319708326450. Epub 2008 Nov 24. Angiology. 2009. PMID: 19033265 Review.
Metoprolol is a selective beta(1)-adrenergic antagonist extensively used since 1975. ...A 100-mg metoprolol controlled/extended-release tablet contains 95 mg of metoprolol succinate and is considered to have equivalent activity of 100 mg metoprolol tar
Metoprolol is a selective beta(1)-adrenergic antagonist extensively used since 1975. ...A 100-mg metoprolol controlled/extende
Drug therapy: metoprolol.
Koch-Weser J. Koch-Weser J. N Engl J Med. 1979 Sep 27;301(13):698-703. doi: 10.1056/NEJM197909273011306. N Engl J Med. 1979. PMID: 225665 Review. No abstract available.
Metoprolol overdose.
Shore ET, Cepin D, Davidson MJ. Shore ET, et al. Ann Emerg Med. 1981 Oct;10(10):524-7. doi: 10.1016/s0196-0644(81)80008-x. Ann Emerg Med. 1981. PMID: 7283217
We report the first two documented cases of the deliberate metoprolol overdose occurring in the United States, one of which eventually proved fatal. The potentially lethal cardiotoxic effects of this drug are illustrated and correlated with the blood and tissue levels of …
We report the first two documented cases of the deliberate metoprolol overdose occurring in the United States, one of which eventuall …
S-metoprolol: the 2008 clinical review.
Dasbiswas A, Shinde S, Dasbiswas D. Dasbiswas A, et al. J Indian Med Assoc. 2008 Apr;106(4):259-62. J Indian Med Assoc. 2008. PMID: 18828349 Review.
This confirms higher cardioselectivity of S-metoprolol in clinical settings. Less interaction potential of S-metoprolol compared to R-isomer further makes it a sensible choice in patients taking CYP2D6 inhibitors or in patients with heart failure or hepatic insuffic …
This confirms higher cardioselectivity of S-metoprolol in clinical settings. Less interaction potential of S-metoprolol compar …
Metoprolol intoxication.
Sire S. Sire S. Lancet. 1976 Nov 20;2(7995):1137. doi: 10.1016/s0140-6736(76)91115-6. Lancet. 1976. PMID: 62972 No abstract available.
Metoprolol (Lopressor).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1978 Nov 3;20(22):97-8. Med Lett Drugs Ther. 1978. PMID: 30035 Clinical Trial. No abstract available.
Pharmacogenomic markers of metoprolol and alpha-OH-metoprolol concentrations: a genome-wide association study.
Laverdière J, Meloche M, Provost S, Leclair G, Oussaïd E, Jutras M, Perreault LL, Valois D, Mongrain I, Busseuil D, Rouleau JL, Tardif JC, Dubé MP, Denus S. Laverdière J, et al. Pharmacogenomics. 2023 Jun;24(8):441-448. doi: 10.2217/pgs-2023-0067. Epub 2023 Jun 12. Pharmacogenomics. 2023. PMID: 37307170
The authors therefore sought to discover the pharmacogenomic markers involved in metoprolol pharmacokinetics. Patients & methods: The authors performed a GWAS of a cross-sectional study of 993 patients from the Montreal Heart Institute Biobank taking metoprolol. …
The authors therefore sought to discover the pharmacogenomic markers involved in metoprolol pharmacokinetics. Patients & methods: …
Extended-release metoprolol succinate in chronic heart failure.
Tangeman HJ, Patterson JH. Tangeman HJ, et al. Ann Pharmacother. 2003 May;37(5):701-10. doi: 10.1345/aph.1C286. Ann Pharmacother. 2003. PMID: 12708950 Review.
DATA SOURCES: A MEDLINE search of English-language literature (1990-October 2002) was conducted using congestive heart failure and metoprolol CR/XL or metoprolol CR/ZOK as search terms to identify pertinent studies. STUDY SELECTION/DATA EXTRACTION: All of the articl …
DATA SOURCES: A MEDLINE search of English-language literature (1990-October 2002) was conducted using congestive heart failure and metopr
9,058 results